Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 October 2022 | Story Anthony Mthembu | Photo Kaleidoscope
Tobias van den Bergh
Tobias van den Bergh, President of the Southern African Association for Counselling and Development in Higher Education (SAACHDE)

Tobias van den Bergh, Counselling Psychologist at the University of the Free State, has been appointed as the President of the Southern African Association for Counselling and Development in Higher Education (SAACDHE).  The appointment became official at the annual SAACDHE conference, which took place in Pretoria from 12 to 14 September 2022. As such, van den Bergh perceives this appointment as an opportunity: “To be part of a creative process that tackles the challenges faced in higher education and knowing the difficulty that students and my colleagues across the country are struggling with, accepting this appointment felt right.”

The role of SAACDHE

“The organisation represents members of several higher education counselling and career development centres from the SADC region. The organisation’s mission is to promote, guide, and advance best practices in centres at institutions of higher education,” explained Van den Bergh. Through this representation and assistance, members are able to provide quality support to the students they serve. SAACDHE members include mental health professionals, social workers, HIV/AIDS counsellors, researchers, and career development specialists from more than 15 higher education institutions in South Africa and Botswana. Furthermore, Van den Bergh asserts that, “SAACDHE represents its members through lobbying for increased institutional support, the promotion of scholarly, ethical, and best practices, and the training and development of professionals.”

Van den Bergh as President of the organisation

 As the newly elected President of the organisation, there are several challenges that Van den Bergh believes require the immediate attention of SAACDHE.  For instance, he maintains that student populations and the mental health challenges they face have grown at a substantial rate over the past few decades. However, the staff capacity in counselling and career development centres has not increased commensurately. As such, the challenge in this regard is that the need for mental health interventions continues to grow, but the capacity is not sufficient to deal with those challenges and to fill the gap in public mental health services. To address this challenge, he indicates that “the organisation is striving to innovate counselling centres, and to find ways to work smarter and be preventative where possible”.

In addition, Van den Bergh is adamant about ensuring that the organisation continues to be innovative in the way mental health services are provided to students, and to create practices that are culturally and contextually relevant. However, his long-term vision for the organisation is, “to continue serving as a training, development, and practice-based organisation, so that we can equip members with support and knowledge that will help them to continue helping students in a smarter and better way”.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept